A field guide to BPC-157The criteria
PRODUCT / CARE / COMMITMENT
Open the provider file

Research explained

BPC-157 after bile-duct ligation

The model does not establish treatment of human cirrhosis or biliary obstruction.

On this page

Read the experiment

The finding and its boundary

The investigators reported attenuation of the bile-duct-ligation syndrome under several regimens. The model does not establish treatment of human cirrhosis or biliary obstruction.

Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation.

Experiment
Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
Study system
Rats with surgically obstructed bile drainage
Measured outcome
Liver injury, fibrosis-related tissue findings, pressure and biochemical measures
Reported result
The investigators reported attenuation of the bile-duct-ligation syndrome under several regimens.
What this cannot establish
The model does not establish treatment of human cirrhosis or biliary obstruction.
Open the primary paper

What was actually tested

Rats with surgically obstructed bile drainage. The investigators measured liver injury, fibrosis-related tissue findings, pressure and biochemical measures. The investigators reported attenuation of the bile-duct-ligation syndrome under several regimens.

The detail that changes the takeaway

A mechanical obstruction is an essential part of the disease model. The observation of less fibrosis-related injury does not show that every cause of fibrosis responds similarly. Treatment beginning around surgery and delayed treatment should also remain distinct when the result is summarized.

How far the result travels

The model does not establish treatment of human cirrhosis or biliary obstruction.

A useful comparison

BPC-157 after sagittal-sinus ligation in rats examines venography, pressure, tissue injury and systemic vascular measures. Here, the measured endpoint was liver injury, fibrosis-related tissue findings, pressure and biochemical measures. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the BPC-157 and experimental pancreatitis: many organ measurements are still one rat model appraisal.

References & product documents

The evidence and service information used here.

  1. BPC-157 after bile-duct ligation — original indexed research

Next in the field guide

The provider file
  1. 01

    BPC-157 after sagittal-sinus ligation in rats

    A ligation model is not evidence of safe treatment for a person's cerebral venous thrombosis.

  2. 02

    BPC-157 and experimental pancreatitis: many organ measurements are still one rat model

    The 2022 paper examined bile-duct ligation and associated vascular disturbances. It did not test human pancreatitis care.

  3. 03

    BPC-157 in an episcleral-vein rat glaucoma model

    The surgically created outflow model does not establish human glaucoma treatment or safe eye drops.

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review